Peering Into Dermata Therapeuticss Recent Short Interest - Benzinga
DRMA Stock | USD 1.10 0.05 4.35% |
About 61% of Dermata Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Dermata Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Dermata Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Dermata Therapeutics stock news signals to limit their universe of possible portfolio assets.
Dermata |
Peering Into Dermata Therapeuticss Recent Short Interest Benzinga
Read at news.google.com
Dermata Therapeutics Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Dermata Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Dermata Therapeutics Fundamental Analysis
We analyze Dermata Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dermata Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dermata Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Target Price
Target Price Comparative Analysis
Dermata Therapeutics is currently under evaluation in target price category among its peers.
Dermata Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dermata Therapeutics stock to make a market-neutral strategy. Peer analysis of Dermata Therapeutics could also be used in its relative valuation, which is a method of valuing Dermata Therapeutics by comparing valuation metrics with similar companies.
Peers
Dermata Therapeutics Related Equities
IMMX | Immix Biopharma | 19.39 | ||||
WINT | Windtree Therapeutics | 8.89 | ||||
REVB | Revelation Biosciences | 0.67 | ||||
PHIO | Phio Pharmaceuticals | 0.00 | ||||
ZURA | Zura Bio | 0.33 | ||||
ATNF | 180 Life | 0.45 | ||||
CDIO | Cardio Diagnostics | 3.23 | ||||
ZVSA | ZyVersa Therapeutics | 3.60 | ||||
CYTO | Altamira Therapeutics | 4.17 | ||||
HEPA | Hepion Pharmaceuticals | 4.33 | ||||
SONN | Sonnet Biotherapeutics | 5.05 | ||||
ENSC | Ensysce Biosciences | 8.87 |
Complementary Tools for Dermata Stock analysis
When running Dermata Therapeutics' price analysis, check to measure Dermata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermata Therapeutics is operating at the current time. Most of Dermata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dermata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermata Therapeutics' price. Additionally, you may evaluate how the addition of Dermata Therapeutics to your portfolios can decrease your overall portfolio volatility.
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Money Managers Screen money managers from public funds and ETFs managed around the world |